Maybe some news coming this afternoon23 Apr 2024 13:58
Next Tuesday, 23rd April 2024, Scancell Ltd CEO Lindy Durrant is presenting at the 8th annual Immuno-Oncology Summit Europe, hosted by Cambridge Healthtech Institute in London. Professor Durrant, will be speaking in the Therapeutic Cancer Vaccines program, where emphasis on clinical studies will be highlighted.
Lindy’s presentation, “Clinical Update on the DC Targeting Melanoma Vaccine, SCIB1 and the Modi-1 Vaccine Targeting Citrullination,” will take place from 2:45 pm – 3:15 pm BST sharing exciting results on SCIB1, Scancell’s ‘off the shelf’ ImmunoBody® #cancervaccine, which has demonstrated positive efficacy data from the Phase 2 SCOPE trial for advanced unresectable #melanoma, as well as Modi-1 as a monotherapy in range of hard-to-treat solid #tumours.
"Following on from #AACR24, there has been significant interest in the clinical development of therapeutic cancer vaccines, and I am excited to demonstrate the progress Scancell has made in this class of immunotherapies." - Professor Lindy Durrant